-The Indian Express As the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) enters its 10th year on Monday, data shows households have been provided employment for just a little over one third of the mandated 100 days so far this financial year on an average. By March end, this could improve a bit, but still end up among the lowest averages since the inception of the Act. According to data available...
More »SEARCH RESULT
State needs to have a pro-Poor minor mineral policy -Manas Jena
-The Pioneer Bhubaneswar: With the increasing demand for building and construction materials in a rapid urbanisation and industrialisation process in the State, the use of minor minerals has been increasing. The housing and road communication projects, both in rural and urban areas and industrial hubs, have created huge demand for minor minerals that have raised concern for an effective minor mineral management policy. It is a fact that in many areas there...
More »No Central Programme as Popular as MNREGA: States
-Outlook New Delhi: There is no central programme as popular as MNREGA; this was some state governments' message to the Centre as they conveyed their displeasure over the fund crunch for the scheme. On the occasion of 10th MNREGA Divas celebrations today, these states narrated how the rural job scheme did "exceptionally well" in the insurgency-hit areas of the country particularly in the northeast and Naxal-affected districts. The northeastern states conveyed their difficulties...
More »Sanitation in schools
-The Hindu The inequities in infrastructure could not be starker. While several schools continue to deny the most basic sanitation facilities for Poorer children, a select band of them dangle air-conditioned classrooms and dormitories and other accessories before the more affluent ones. Repeated knuckle-rapping by the Supreme Court over the years has evidently had little effect on State administrations, as the case of Andhra Pradesh and Telangana illustrates. In October...
More »More patent-opposition on Gilead’s hepatitis C drug, sofosbuvir -PT Jyothi Datta
-The Hindu Business Line Mumbai: A fresh bout of opposition has been filed against Gilead's patent application on hepatitis c drug sofosbuvir. This comes close on the heels of a spate of developments involving the drug, last month. Non-government organisation Sankalp Rehabilitation Trust, represented by the Lawyers Collective has filed a pre-grant opposition on the drug in the Delhi patent office. (A pre-grant opposition allows interested parties to oppose a patent application...
More »